Skip to main content
logo
XTL Biopharmaceuticals Ltd. (TLV:XTLB)
Israel flag Israel · Delayed Price · Currency is ILS · Price in ILA
1.900
0.00 (0.00%)
Sep 8, 2026, 5:24 PM IDT

XTL Biopharmaceuticals Ratios and Metrics

Millions ILS. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
252382192247
Market Cap Growth
-33.60%-72.15%327.50%-14.63%-52.02%-7.60%
Enterprise Value
25227511737
Last Close Price
0.020.020.070.040.040.09

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
-----34.41
PB Ratio
-31.08-28.044.122.381.592.81
P/TBV Ratio
---2.881.763.02

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
--0.03---
Net Debt / Equity Ratio
0.300.30-0.18-0.90-0.93-1.15
Net Debt / EBITDA Ratio
0.060.061.752.634.235.95
Net Debt / FCF Ratio
0.070.070.602.844.135.84
Quick Ratio
0.180.180.569.7419.9026.52
Current Ratio
0.400.400.619.9320.3527.00
Return on Equity (ROE)
-29.30%-29.30%6.27%-57.31%-28.89%9.73%
Return on Assets (ROA)
-21.01%-21.01%-8.83%-14.46%-10.18%-9.82%
Return on Capital Employed (ROCE)
576.80%576.80%-12.20%-34.50%-22.00%-16.10%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-88.29%-97.83%-4.59%-33.65%-21.22%2.91%
FCF Yield
-12.35%-14.39%-7.47%-13.35%-14.18%-7.01%
Buyback Yield / Dilution
-52.32%-33.15%-23.52%0.00%11.48%-19.71%